A Study to Measure the Degree and Effectiveness of the Various vSculpt Operating Modes
A Pilot Study to Determine the Degree and Effectiveness of the Various Operating Modes of vSculpt on Enhancing Genital Blood Flow and Improving Quality of Life in Women Who Experience Sexual Dysfunction and Stress Incontinence
1 other identifier
interventional
6
1 country
1
Brief Summary
A pilot study to determine the degree and effectiveness of the various modes of vSculpt, an over-the-counter "OTC" medical device, on enhanced genital blood flow and improvement in quality of life in menopausal women who suffer sexual dysfunction and stress incontinence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 2, 2016
CompletedFirst Posted
Study publicly available on registry
August 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedResults Posted
Study results publicly available
October 26, 2021
CompletedNovember 24, 2021
August 1, 2016
5 months
August 2, 2016
August 19, 2020
October 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Blood Flow as Measured by Temperature Change in the Genitalia Using Thermography Technology
The primary outcomes assessed will be change in blood flow as measured by temperature change in Celsius in the genitalia using thermography technology.
Pre and post treatment at baseline and pre and post treatment at day 30
Secondary Outcomes (4)
Patient Quality of Life as Measured by Female Sexual Function Index (FSFI) Scores at Baseline and 30 Days Post Treatment.
Baseline and 30 days
Patient Quality of Life as Measured by Female Sexual Distress Scores (FSDS) at Baseline and 30 Days Post Treatment.
Baseline and 30 days
Patient Quality of Life as Measured by the Urogenital Distress Inventory, Short Form (UDI-6)
Baseline and 30 days
Patient Quality of Life as Measured by the Incontinence Impact Questionnaire, Short Form (IIQ-7)
Baseline and 30 days
Study Arms (3)
vSculpt with Vibration Only
ACTIVE COMPARATORvSculpt genital device used in vibration mode only.
vSculpt with Vibration and Light
ACTIVE COMPARATORvSculpt genital device used in vibration and light mode.
InTone Device
ACTIVE COMPARATORInTone genital device using electric muscle stimulation only.
Interventions
A genital vibration device that operates in two modes, vibration only or vibration and light, to help tone and tighten pelvic floor muscles.
A genital device using electric muscle stimulation to treat incontinence.
Eligibility Criteria
You may qualify if:
- Study participants will be female
- Female participants who are capable of giving informed consent
- Female participants who are menopausal who have not had a menses within one year, and are within the ages of 48 and 60
- Female participants who have had one or more vaginal births
- Female participants who are currently engaged in vaginal sexual intercourse with a partner
- Female participants who are presently experiencing bladder control issues either leakage, frequency or urgency
- Female participants who are presently experiencing pain during sexual intercourse
You may not qualify if:
- Female participants shall not have an active sexually transmitted disease and/or infection
- Female participants who are actively undergoing chemotherapy
- Female participants who are currently taking any cancer-related drugs
- Female participants who are breastfeeding or lactating
- Female participants who have a medical history of neurological disorders (e.g., multiple sclerosis, Parkinson's disease)
- Female participants with an active urinary tract infection (UTI)
- Female participants with active bladder stones
- Female participants with active bladder tumor(s)
- Females with prior laser or vaginal rejuvenation surgeries or treatments
- Females with a medical history of vaginal cancer or radiation or surgery with exception of related to childbirth
- Females with prior non-invasive treatments (estrogen cream) or pelvic floor physical therapy for the vaginal area/ pelvic floor in the past six month
- Females with a physical disability precluding her from holding a lithotomy for an hour
- Females who are homeless
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Joylux, Inc.lead
Study Sites (1)
San Diego Sexual Medicine
San Diego, California, 92120, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Colette Courtion
- Organization
- Joylux
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2016
First Posted
August 5, 2016
Study Start
July 1, 2016
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
November 24, 2021
Results First Posted
October 26, 2021
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share